Intervention not reported
Albumin plus noradrenaline (1 RCT; 46 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (1 RCT; 46 participants) (very low certainty).
1 finding from 1 review
OR 0.16 [0.01, 1.44]
Studies not reported
Very low
Intervention not reported
Albumin plus terlipressin · people with hepatorenal syndrome with decompensated liver cirrhosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Albumin plus noradrenaline (4 RCTs; 293 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
The intervention may leads to lower albumin plus noradrenaline (4 RCTs; 293 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Albumin (1 RCT; 48 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin (1 RCT; 48 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Albumin plus noradrenaline (1 RCT; 48 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (1 RCT; 48 participants) (very low certainty).
1 finding from 1 review
HR 1.09 [0.36, 3.31]
Studies not reported
Very low
Intervention not reported
Albumin plus noradrenaline (10 RCTs; 518 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (10 RCTs; 518 participants) (very low certainty).
1 finding from 1 review
HR 0.85 [0.58, 1.28]
Studies not reported
Very low
Intervention not reported
Albumin (4 RCTs; 406 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin (4 RCTs; 406 participants) (very low certainty).
1 finding from 1 review
HR 0.28 [0.14, 0.53]
Studies not reported
Very low
Intervention not reported
Albumin plus noradrenaline (9 RCTs; 486 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (9 RCTs; 486 participants) (very low certainty).
1 finding from 1 review
HR 1.33 [0.87, 2]
Studies not reported
Very low
Intervention not reported
Albumin (6 RCTs; 480 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin (6 RCTs; 480 participants) (very low certainty).
1 finding from 1 review
HR 1.06 [0.69, 1.8]
Studies not reported
Very low
Intervention not reported
Albumin plus midodrine plus octreotide (1 RCT; 48 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus midodrine plus octreotide (1 RCT; 48 participants) (very low certainty).
1 finding from 1 review
HR 1.42 [0.52, 3.79]
Studies not reported
Very low
Intervention not reported
Albumin plus midodrine plus octreotide plus pentoxifylline (No RCTs) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus midodrine plus octreotide plus pentoxifylline (No RCTs) (very low certainty).
1 finding from 1 review
HR 0.5 [0.06, 4.07]
Studies not reported
Very low
Intervention not reported
Albumin plus octreotide (1 RCT; 40 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus octreotide (1 RCT; 40 participants) (very low certainty).
1 finding from 1 review
HR 1.46 [0.35, 6.49]
Studies not reported
Very low
Intervention not reported
Albumin plus noradrenaline (1 RCT; 120 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus noradrenaline (1 RCT; 120 participants) (very low certainty).
1 finding from 1 review
OR 0.82 [0.21, 2.98]
Studies not reported
Very low
Intervention not reported
Albumin (2 RCTs; 308 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin (2 RCTs; 308 participants) (very low certainty).
1 finding from 1 review
OR 0.8 [0.5, 1.26]
Studies not reported
Very low
Intervention not reported
Albumin (1 RCT; 46 participants) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin (1 RCT; 46 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Interventions · people with cirrhosis and spontaneous bacterial peritonitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Liver transplantation · people with cirrhosis and spontaneous bacterial peritonitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Ciprofloxacin (2 RCT; 275 participants) · people with cirrhosis and spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes ciprofloxacin (2 RCT; 275 participants) (very low certainty).
1 finding from 1 review
HR 0.93 [0.69, 1.25]
Studies not reported
Very low
Intervention not reported
Cefotaxime (1 RCT; 37 participants) · people with cirrhosis and spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes cefotaxime (1 RCT; 37 participants) (very low certainty).
1 finding from 1 review
HR 0.56 [0.11, 2.28]
Studies not reported
Very low
Intervention not reported
Ciprofloxacin (1 RCT; 35 participants) · people with cirrhosis and spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes ciprofloxacin (1 RCT; 35 participants) (very low certainty).
1 finding from 1 review
HR 0.65 [0.12, 2.72]
Studies not reported
Very low